{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:53:01Z","timestamp":1793141581765,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.semarthrit.2025.152736","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:27:32Z","timestamp":1744871252000},"page":"152736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Factors associated with thrombosis in Beh\u00e7et Syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"73","author":[{"given":"Gul","family":"Guzelant-Ozkose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Yurttas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5414-7305","authenticated-orcid":false,"given":"Sinem Nihal","family":"Esatoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhlis Cem","family":"Ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Hamuryudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulen","family":"Hatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00296-005-0590-1","article-title":"Endothelial functions in Behcet's disease","volume":"26","author":"Kayikcioglu","year":"2006","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152736_bib0002","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/rheumatology\/kead476","article-title":"Common femoral vein wall thickness measurement as a diagnostic test in suspected Behcet's disease","volume":"63","author":"Alibaz-Oner","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152736_bib0003","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s10067-019-04470-z","article-title":"Venous vessel wall thickness in lower extremity is increased in male patients with Behcet's disease","volume":"38","author":"Alibaz-Oner","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152736_bib0004","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jvsv.2018.11.006","article-title":"Increased vein wall thickness in Behcet disease","volume":"7","author":"Seyahi","year":"2019","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152736_bib0005","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0006","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/rheumatology\/kez352","article-title":"Clinical course of acute deep vein thrombosis of the legs in Behcet's syndrome","volume":"59","author":"Ozguler","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152736_bib0007","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/rheumatology\/key242","article-title":"Management of major organ involvement of Behcet's syndrome: a systematic review for update of the EULAR recommendations","volume":"57","author":"Ozguler","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2025.152736_bib0008","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2019-eular.4890","article-title":"AB0573\u2005Assessment of presence, severity and risk factors of post- thrombotic syndrome in vascular beh\u00e7et disease: muticentered retrospective study","volume":"78","author":"Aksoy","year":"2019","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152736_bib0009","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.autrev.2012.11.001","article-title":"Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behcet's disease: a systematic review and meta-analysis","volume":"12","author":"Chamorro","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152736_bib0010","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1055\/s-0041-1740637","article-title":"Plasma homocysteine in Behcet's Disease: a systematic review and meta-analysis","volume":"122","author":"Merashli","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0011","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.6000\/1929-6029.2015.04.01.6","article-title":"Estimating mean and Standard deviation from the sample size, three quartiles, minimum, and maximum","volume":"4","author":"Bland","year":"2014","journal-title":"Int J Statist Med Res"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152736_bib0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365513.2018.1488179","article-title":"The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behcet's disease","volume":"78","author":"Sertoglu","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","article-title":"Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin","volume":"112","author":"Espinosa","year":"2002","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0016","first-page":"S23","article-title":"Protein Z G79A and A-13G gene polymorphisms in Italian patients with Behcet's disease","volume":"27","author":"Ghinoi","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0017","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1160\/TH05-10-0659","article-title":"Thrombophilic risk factors and homocysteine levels in Behcet's disease in eastern Spain and their association with thrombotic events","volume":"95","author":"Ricart","year":"2006","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0018","first-page":"S67","article-title":"Endogenous thrombin potential in Behcet's disease: relationship with thrombosis and anticoagulant therapy","volume":"32","author":"Mejia","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152736_bib0019","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/ard.2003.014241","article-title":"Thrombophilic factors are not the leading cause of thrombosis in Behcet's disease","volume":"63","author":"Leiba","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152736_bib0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000077824","article-title":"Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behcet's disease","volume":"33","author":"Ates","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0021","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jbspin.2010.02.022","article-title":"A study on thrombophilic factors in Italian Behcet's patients","volume":"77","author":"Caramaschi","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0022","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00001721-200302000-00001","article-title":"Factor V Leiden mutation and PAI-1 gene 4G\/5G genotype in thrombotic patients with Behcet's disease","volume":"14","author":"Gurgey","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152736_bib0023","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/38.12.1298","article-title":"Procoagulant mutations and venous thrombosis in Behcet's disease","volume":"38","author":"Gul","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0024","first-page":"5","article-title":"Activation parameters in Beh\u00e7et's disease","volume":"22","author":"Tursen","year":"2014","journal-title":"Hong Kong J Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/art.20237","article-title":"Factor V leiden and prothrombin gene G20210A mutations in Italian patients with Beh\u00e7et's disease and deep vein thrombosis","volume":"51","author":"Silingardi","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0026","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/gtmb.2011.0096","article-title":"Vascular behcet and mutations in thrombogenic genes: methylene tetrahydrofolate reductase, factor V, and prothrombin","volume":"16","author":"Dagan","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152736_bib0027","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9394(99)00184-1","article-title":"Factor V Leiden mutation is associated with ocular involvement in Beh\u00e7et disease","volume":"128","author":"Verity","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152736_bib0028","first-page":"2196","article-title":"Association of factor V Leiden with Beh\u00e7et's disease","volume":"24","author":"Mammo","year":"1997","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152736_bib0029","first-page":"2849","article-title":"Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Beh\u00e7et's disease","volume":"27","author":"Toydemir","year":"2000","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0030","first-page":"21","article-title":"Association between Factor V Leiden gene mutation and systemic involvement in Behcet's disease","volume":"43","author":"Cebeci","year":"2009","journal-title":"Turkderm-Turk Arch Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152736_bib0031","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0420.2003.00068.x","article-title":"Factor V leiden and prothrombin gene G20210A mutations in ocular Beh\u00e7et disease","volume":"81","author":"Batio\u011flu","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0032","first-page":"22","article-title":"Factor V leiden mutation in Beh\u00e7et's disease","volume":"9","author":"Soy","year":"2000","journal-title":"Annal Med Sci"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152736_bib0033","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/35.11.1178","article-title":"Coagulation factor V gene mutation increases the risk of venous thrombosis in beh\u00e7et's disease","volume":"35","author":"G\u00fcl","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152736_bib0034","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/rheumatology\/40.6.687","article-title":"Hyperhomocysteinaemia in Beh\u00e7et's disease","volume":"40","author":"Aksu","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00296-003-0398-9","article-title":"Serum homocysteine level is higher in Beh\u00e7et's disease with vascular involvement","volume":"25","author":"Ate\u015f","year":"2005","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152736_bib0036","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00296-003-0301-8","article-title":"Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Beh\u00e7et's disease","volume":"23","author":"Canataroglu","year":"2003","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152736_bib0037","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s10067-008-0889-x","article-title":"Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Beh\u00e7et's disease","volume":"27","author":"D\u00fczg\u00fcn","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152736_bib0038","first-page":"1417","article-title":"Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Beh\u00e7et's disease","volume":"42","author":"Feki","year":"2004","journal-title":"Clin Chem Laborat Med (CCLM)"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152736_bib0039","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/0019-5154.70667","article-title":"Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in beh\u00e7et's disease","volume":"55","author":"Hodeib","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/407972","article-title":"Homocysteine may involve in the pathogenesis of Behcet's disease by inducing inflammation","volume":"2008","author":"Kartal Durmazlar","year":"2008","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0041","first-page":"S30","article-title":"Is there an association of plasma homocysteine levels with vascular involvement in patients with Beh\u00e7et's syndrome?","volume":"20","author":"Korkmaz","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0042","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1479-8077.2007.00286.x","article-title":"Serum homocystein level and vascular thrombosis in patients with Beh\u0ffdet disease","volume":"10","author":"Nazarinia","year":"2007","journal-title":"Aplar Journal of Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0043","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4314\/eamj.v83i1.9361","article-title":"Effect of Helicobacter pylori infection on deep vein thrombosis seen in patients with Beh\u00e7et's disease","volume":"83","author":"Sent\u00fcrk","year":"2006","journal-title":"East Afr Med J"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152736_bib0044","first-page":"476","article-title":"Plasma homocysteine level in patients with Behcet's disease with or without thrombosis","volume":"13","author":"Shahram","year":"2010","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0045","first-page":"440","article-title":"Vascular involvements in Beh(c)et's disease: a retrospective clinical study of 41 cases","author":"Shao","year":"2018","journal-title":"Chinese Journal of Rheumatology"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152736_bib0046","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00296-004-0466-9","article-title":"Hyperhomocysteinemia in patients with Beh\u00e7et's disease: is it due to inflammation or therapy?","volume":"25","author":"Yesilova","year":"2005","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152736_bib0047","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5114\/aoms.2018.79139","article-title":"Evaluation of atherogenic laboratory markers in Behcet's disease patients with vascular involvement","volume":"16","author":"Yucel","year":"2020","journal-title":"Arch Med Sci"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0048","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2141.2004.05072.x","article-title":"Activated protein C levels in Behcet's disease and risk of venous thrombosis","volume":"126","author":"Navarro","year":"2004","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0049","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.18295\/2075-0528.1571","article-title":"Haemostatic parameters in patients with Behcet's Disease","volume":"14","author":"Alkaabi","year":"2014","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0050","first-page":"305","article-title":"Von Willebrand factor in Behcet's syndrome","volume":"14","author":"Yazici","year":"1987","journal-title":"J Rheumatol"},{"issue":"14","key":"10.1016\/j.semarthrit.2025.152736_bib0051","first-page":"3045","article-title":"Neutrophil\/lymphocyte ratio and mean platelet volume in Behcet's disease","volume":"20","author":"Balkarli","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0052","first-page":"5304","article-title":"Which one is best? Platelet\/lymphocyte ratio, neutrophil\/lymphocyte ratio or both in determining deep venous thrombosis in behcet\u2019s disease?","volume":"28","author":"Erden","year":"2017","journal-title":"Biomedical Research (India)"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0053","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MBC.0b013e328330bdc4","article-title":"Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behcet's disease? A comparative study","volume":"21","author":"Pamuk","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152736_bib0054","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07078.x","article-title":"Fibrinolytic inhibitor levels and polymorphisms in Behcet disease and their association with thrombosis","volume":"141","author":"Ricart","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/OARRR.S225168","article-title":"Assessment of circulating endothelial cells and their progenitors As potential biomarkers of disease activity and damage accrual In Behcet's syndrome","volume":"11","author":"Floris","year":"2019","journal-title":"Open Access Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152736_bib0056","first-page":"105","article-title":"Circulating endothelial cells in Behcet's disease: is there a relationship with vascular involvement?","volume":"37","author":"Yasar Bilge","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0057","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/14397595.2013.854071","article-title":"Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement","volume":"24","author":"Bassyouni","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0058","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0973-3698(11)60202-1","article-title":"Role of vascular endothelial growth factor and monocyte chemoattractant protein-1 in Beh\u00e7et's disease","volume":"6","author":"Ibrahim","year":"2011","journal-title":"Indian Journal of Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0059","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2133.2006.07536.x","article-title":"The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behcet disease","volume":"156","author":"Shaker","year":"2007","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0060","first-page":"S42","article-title":"Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behcet's patients with venous thrombosis","volume":"23","author":"Bozoglu","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0061","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000112635","article-title":"Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behcet's disease: are they related to thrombotic events?","volume":"36","author":"Martinez","year":"2007","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152736_bib0062","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/1756-185X.13151","article-title":"The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behcet's disease","volume":"21","author":"Cosan","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0063","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2008-1027716","article-title":"Increased circulating asymmetric dimethylarginine (ADMA) levels in the active stage of Beh\u00e7et\u2019s Syndrome","volume":"34","author":"Terekeci","year":"2009","journal-title":"Aktuelle Rheumatologie - Aktuel Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0064","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00262712","article-title":"Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behcet's disease","volume":"15","author":"Aydintug","year":"1995","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0065","first-page":"S35","article-title":"MEFV mutations are increased in Behcet's disease (BD) and are associated with vascular involvement","volume":"21","author":"Atagunduz","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152736_bib0066","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1742-1241.2005.00477.x","article-title":"Impaired endothelium-dependent flow-mediated dilation in Behcet's disease: more prominent endothelial dysfunction in patients with vascular involvement","volume":"59","author":"Oflaz","year":"2005","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0067","first-page":"S70","article-title":"Serum MMP-2 and MMP-9 in patients with Behcet's disease: do their higher levels correlate to vasculo-Behcet's disease associated with aneurysm formation?","volume":"25","author":"Pay","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0068","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ebiom.2016.03.009","article-title":"HnRNP A1 is involved in deep vein thrombosis patients with Behcet's disease","volume":"6","author":"Chen","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152736_bib0069","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s00380-015-0686-9","article-title":"Clinical significance of Angiopoietin-1 in Behcet's disease patients with vascular involvement","volume":"31","author":"Bassyouni","year":"2016","journal-title":"Heart Vessels"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152736_bib0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5152\/eurjrheum.2023.23007","article-title":"Matrix metalloproteinase-2 and -3 levels in patients with Behcet's disease and implication for the presence of vascular aneurysm or neurologic involvement","volume":"10","author":"Talu Erten","year":"2023","journal-title":"Eur J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0071","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1076029611427440","article-title":"JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome","volume":"18","author":"Ar","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152736_bib0072","first-page":"791","article-title":"[Activated protein C resistance in Behcet disease]","volume":"46","author":"Guermazi","year":"1998","journal-title":"Pathol Biol (Paris)"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0073","first-page":"S53","article-title":"Fibrinolytic activity and d-dimer levels in Behcet's syndrome","volume":"23","author":"Yurdakul","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152736_bib0074","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11739-018-1991-y","article-title":"Vascular Behcet's syndrome: an update","volume":"14","author":"Emmi","year":"2019","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3389\/fimmu.2019.01085","article-title":"Behcet's Syndrome as a model of thrombo-inflammation: the role of neutrophils","volume":"10","author":"Emmi","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105277","article-title":"Analysis of vascular involvement in 460 patients with Behcet's syndrome: clinical characteristics and associated factors","volume":"89","author":"Torgutalp","year":"2022","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152736_bib0077","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152736_bib0078","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/1529-0131(200111)44:11<2693::AID-ART449>3.0.CO;2-M","article-title":"Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23","volume":"44","author":"Gul","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0079","first-page":"215","article-title":"A structural locus for coagulation factor XIIIA (F13A) is located distal to the HLA region on chromosome 6p in man","volume":"37","author":"Olaisen","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0080","article-title":"Factor XIII-A transglutaminase contributes to neutrophil extracellular trap (NET)-mediated fibrin(ogen) network formation and crosslinking","author":"Soltani","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0081","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1172-8-81","article-title":"Behcet's disease: new insight into the relationship between procoagulant state, endothelial activation\/damage and disease activity","volume":"8","author":"Fernandez-Bello","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152736_bib0082","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood.V85.10.2756.bloodjournal85102756","article-title":"Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)","volume":"85","author":"Koster","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0083","article-title":"Protein S deficiency,\" in StatPearls","author":"Gupta","year":"2024","journal-title":"Treasure Island (FL)"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152736_bib0084","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0496-386","article-title":"Homocysteine and vascular disease","volume":"2","author":"McCully","year":"1996","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152736_bib0085","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/01.CIR.96.8.2542","article-title":"Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans","volume":"96","author":"Woo","year":"1997","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.semarthrit.2025.152736_bib0086","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199504063321403","article-title":"Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men","volume":"332","author":"Ridker","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Factor V Leiden thrombophilia","volume":"13","author":"Kujovich","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0088","series-title":"GeneReviews((R))","article-title":"Prothrombin thrombophilia","author":"Kujovich","year":"1993"},{"issue":"22","key":"10.1016\/j.semarthrit.2025.152736_bib0089","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152736_bib0090","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10654-013-9825-8","article-title":"Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls","volume":"28","author":"Simone","year":"2013","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152736_bib0091","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0049-3848(99)00157-7","article-title":"Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients","volume":"97","author":"Akar","year":"2000","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152736_bib0092","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1076029607305110","article-title":"The role of plasminogen activator inhibitor-1 polymorphism, factor-V-leiden, and prothrombin-20210 mutations in pulmonary thromboembolism","volume":"15","author":"Oguzulgen","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0093","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1076029607305620","article-title":"Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism","volume":"14","author":"Okumus","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152736_bib0094","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2257.1999.00210.x","article-title":"The investigation and management of inherited thrombophilia","volume":"21","author":"Cumming","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.semarthrit.2025.152736_bib0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/asheducation-2007.1.127","article-title":"Thrombophilia: common questions on laboratory assessment and management","author":"Heit","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T21:59:10Z","timestamp":1751579950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":95,"alternative-id":["S0049017225001076"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152736","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with thrombosis in Beh\u00e7et Syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152736"}}